Clinical Trial Update: Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update on a conversion study of Gengraf (tacrolimus) in stable renal allograft transplant recipients, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• GENGRAF (cyclosporine)

Snippet

Sponsor: Penang Hospital, Malaysia | Conditions: End Stage Renal Failure | Phase 4 | Status: COMPLETED